Marea is a biotechnology company that develops therapies and medications for the treatment of cardioendocrine illness patients.
Marea Therapeutics has raised $190.0M in total funding. The most recent round was Series B. The last funding was announced in June 2024.
Marea Therapeutics's investors include Alpha Wave Global, Perceptive Advisors, Sofinnova Investments, Forbion Capital Partners, Third Rock Ventures.
Marea Therapeutics is headquartered in San Francisco, United States.
Marea is a biotechnology company that develops therapies and medications for the treatment of cardioendocrine illness patients.
Marea Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Marea Therapeutics — Funding & Investors." VCBacked, June 18, 2024, https://www.vcbacked.co/company/marea-therapeutics. Accessed November 12, 2026.
VCBacked. (2024). Marea Therapeutics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/marea-therapeutics
{{cite web |title=Marea Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/marea-therapeutics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Marea Therapeutics? Request a listing update